PNC Financial Services Group’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-826
Closed -$2.6K 5151
2025
Q3
$2.6K Sell
826
-3,157
-79% -$8.66K ﹤0.01% 4428
2025
Q2
$9K Buy
3,983
+2,204
+124% +$6.28K ﹤0.01% 3916
2025
Q1
$4.75K Buy
+1,779
New +$5.53K ﹤0.01% 4087
2014
Q2
Sell
-21
Closed -$536K 3802
2014
Q1
$536K Buy
21
+6
+40% +$147K ﹤0.01% 1364
2013
Q4
$266K Buy
15
+2
+15% +$35.1K ﹤0.01% 1730
2013
Q3
$262K Buy
+13
New +$269K ﹤0.01% 1710

Other funds holding ACHV

PNC Financial Services Group's ACHV Position: Q4 2025 in Review

PNC Financial Services Group sold out of Achieve Life Sciences (ACHV) in Q4 2025, closing a stake of 826 shares — an estimated $2.6K sold.

PNC Financial Services Group first reported a position in ACHV in Q3 2013 and held it in 6 quarters. The position peaked at $536K in Q1 2014. 77 funds tracked by Wall St. Rank hold ACHV as of Q4 2025.

  • PNC Financial Services Group reported no remaining Achieve Life Sciences position as of Q4 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 826 Achieve Life Sciences shares in Q4 2025, an estimated $2.6K.
  • PNC Financial Services Group first reported a position in Achieve Life Sciences in Q3 2013 and held it in 6 quarters.
  • PNC Financial Services Group's Achieve Life Sciences position peaked at $536K in Q1 2014.
  • 77 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2025.

Based on PNC Financial Services Group's 13F filing for Q4 2025, filed 6 Feb 2026.